Screener
Tyra Biosciences, Inc. TYRA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Tyra Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Tyra Biosciences, Inc.’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 8:03 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-220645
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $84,955 | $77,387 |
| Marketable securities | 298,511 | 178,616 |
| Prepaid expenses and other current assets | 11,147 | 9,447 |
| Total current assets | 394,613 | 265,450 |
| Restricted cash | 884 | 1,000 |
| Property and equipment, net | 1,215 | 1,314 |
| Right-of-use assets | 5,443 | 5,573 |
| Other long-term assets | 9,885 | 9,272 |
Item 1. Condensed Financial Statements
FAQ
- What is Tyra Biosciences, Inc.'s total current assets?
- Tyra Biosciences, Inc. (TYRA) reported total current assets of $394.61M in Q1 2026.
- How has Tyra Biosciences, Inc.'s total current assets changed year-over-year?
- Tyra Biosciences, Inc.'s total current assets increased by 21.6% year-over-year, from $324.57M to $394.61M.
- What is the long-term trend for Tyra Biosciences, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Tyra Biosciences, Inc.'s total current assets has grown at a 77.0% compound annual growth rate (CAGR), from $15.28M to $265.45M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Tyra Biosciences, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude